Tag archive for ‘DCVax Direct Phase 1/2 trial’
Northwest Biotheraputics to Make Presentation at ASCO Today Monday June 5, 2017
Northwest issued a press release announcing a presentation at ASCO today by the Company’s Chief Technical Officer, Dr. Marnix Bosch. The Company said that it will issue updates on: The Phase 3 trial of DCVax-L for newly diagnosed Glioblastoma multiforme (GBM) brain cancer, the Information Arm related to the phase 3 trial and the Company’s […]